Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Tracking the future: 5-Year watch for kids in groundbreaking brain disease gene therapy trial

NCT ID NCT06614569

Summary

This study is monitoring 7 children for five years after they received an experimental gene therapy for Tay-Sachs or Sandhoff disease. The goal is to check for any long-term safety issues, like cancer or immune system problems, that might develop years after the treatment. Researchers will also track how the children are doing to see if the therapy changes the expected course of these severe diseases.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SANDHOFF DISEASE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • UMass Chan Medical School

    Worcester, Massachusetts, 01655, United States

Conditions

Explore the condition pages connected to this study.